SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer

Ekaterina Smirnyagina

Board Member

Katya joined Oxford Science Enterprises as Senior Partner Life Sciences in September 2021 bringing two decades of experience in biotech and has been a director of SpyBiotech since October 2021. Katya started her VC career in 2002 with Alta Partners, a life sciences focused US fund, followed by Capricorn Partners in Belgium.  She has been a director of a number of public and private companies in Europe and is the former Vice-Chair of InvestEurope.  In addition to SpyBiotech she represents Oxford Science Enterprises at the board of directors of MiroBio.

Katya holds a PhD in Cellular & Molecular Biology from the University of Wisconsin-Madison and has completed her scientific training with postdoctoral studies in Microbiology & Immunology at the Stanford University School of Medicine.

Back to team

Read more about our pipeline and the diseases we are working to eradicate.

Our Pipeline